AstraZeneca to receive up to $400 million to co-develop Parkinson’s drug

News

Author: Parkinson's Life editorsPublished: 31 August 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

AstraZeneca and Takeda lead

AstraZeneca is to receive up to $400 million from Takeda Pharmaceutical after agreeing a deal to co-develop an early-stage medicine for Parkinson’s disease.

The drug, MEDI1341, is an antibody treatment and is due to enter phase I clinical trials later this year.

Mene Pangalos, executive vice president of AstraZeneca, said: “By combining our scientific expertise and sharing the risks and cost of development, we hope to accelerate the advancement of MEDI1341 as a promising new approach to support the treatment of people with Parkinson’s disease around the world.”

The two companies will share future development and commercialisation costs for MEDI1341 equally, in addition to future revenues.

Go Back

Share this story

Comments


  • Riley Aria

    There is a breakthrough Parkinson(PD) precursor that i use in getting rid of my PD disease with great benefits. Not sure if I am allowed to share a link via this blog. Anyhow take a look at this if you are able to. If it resonates with you & if you would like more info, I’m happy to oblige,because i really know how much this online store helped my cure my Parkinson disease(PD)this natural product do cure you within few weeks ,actually never thought this would work until i give a try that is what i need from you patients suffering for PD you all really need this.
    totalcureherbalfoundation@gmail.com
    https://totalcureherbalfou.wixsite.com/website

Related articles


Two people dancing

Health & Fitness

‘Performing arts help shake off the burden of Parkinson’s’

We talk to the artist empowering people with Parkinson’s

READ MORE
Portland Sleep and PD

Resources & Tools

Trouble sleeping? Listen to a free podcast about sleep and Parkinson’s

Discussing a common nocturnal nemesis for people with Parkinson's

READ MORE
Sofiya Lysenko holding her science awards.

Interviews

Meet the 17-year-old inventor “treating Parkinson’s from the root”

Student creates a DNA nanorobot for more targeted Parkinson’s treatment

READ MORE